# Taysha Gene Therapies, Inc.: Form SCHEDULE 13D/A, filed Jun 3, 2025

- Company: [Taysha Gene Therapies, Inc.](/companies/tsha.md) (CIK 1806310)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-03
- Accepted by EDGAR: Jun 3, 2025, 21:54 ET
- Period: not reported
- Accession: 0001415889-25-015487
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1806310/000141588925015487/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806310/000141588925015487/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806310/000141588925015487/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-015487. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.